Dr. Reddy’s is an integrated global pharmaceutical company with strong brand presence established through 28 years of history. Dr. Reddy’s is listed on the New York Stock Exchange, headquartered in India, with annual sales of $1.7 billion and products marketed in more than 10 countries.
Dr. Reddy’s launches in Australia
Dr. Reddy's Laboratories Australia Pty Ltd. is a wholly owned subsidiary of Dr. Reddy's Laboratories Ltd., India. In recent few years we have managed to enter this well-regulated market with quality products, responsible business practices and a professional supply chain practice. Dr. Reddy’s commenced its operation in Australia in 2009 and company is now strengthening its operation with the launch of new products.
Our portfolio of products for the Australian market focuses on various therapeutic areas like Gastro-Intestinal, Anti-Infective, Urology, Cardiovascular diseases, Central Nervous System and Anti-Epileptic.
The overall operations of Australia business has expanded their team of professionals in Operations, Sales, Regulatory Affairs and Marketing who work for the company which is now running its operations from Melbourne, Australia. All the local activities of the company for Australia are satisfactorily dealt with by this office.
Looking after Australian Consumers
The Australian Government recognises that generic medicines play an important role in Pharmacy. Generic Medicines improves consumers’ access, supply and affordability of medicine. Dr. Reddy’s Laboratories Australia views the generic market as an opportunity to establish its position in the local industry.